Losa Ferran - Medical Oncology Department, ICO-CSI. Hospital Sant Joan Despí Moisés Broggi

基本信息

浏览量：40

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 157 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

511MO Third Line Rechallenge with Cetuximab (cet) and Irinotecan in Circulating Tumor DNA (ctdna) Selected Metastatic Colorectal Cancer (mcrc) Patients: the Randomized Phase II CITRIC Trial

C. Santos Vivas,J. Vidal Barrull, C. Fernandez Rodriguez,F. Salvà Ballabrera,V. Alonso-Orduna,R. Garcia-Carbonero,F. Losa,N. Tarazona Llavero,M.J. Safont Aguileria,F. Rivera Herrero,L. Layos Romero,M.J. Ortiz Morales,A. Salud,J. Alcaide-Garcia, D. Paez,X. Hernandez-Yagüe,R. Alvarez Gallego, R. Vera,B. Bellosillo Paricio,C. Montagut Viladot

Annals of Oncology (2024)

引用0浏览0引用

Abstract B038: Application of Liquid Biopsy-RECIST (LB-RECIST) Criteria to Track Metastatic Colorectal Cancer (mcrc) Molecular Response in First-Line (1L) Setting: Findings from the PLATFORM-B Study

Valentino Martelli,Joana Vidal, Maria Concepción Fernández-Rodríguez, Pilar García-Alfonso,David Páez,Joan Gibert, Jennifer Linares, Annarita Sibilio, Vicente Alonso,Maria Teresa Cano,Cristina Santos,Gema Duran,Elena Élez,José Luis Manzano,Rocio Garcia-Carbonero,Reyes Ferreiro,Ferran Losa,Estela Pineda,Javier Sastre,Auxiliadora Gomez-España,Rodrigo Toledo,Fernando Rivera,Beatriz Bellosillo,Josep Tabernero, Ramon, Enrique Aranda, Clara Montagut

Clinical Cancer Researchno. 21_Supplement (2024)

引用0浏览0引用

200P Outcomes of Patients (pts) with Unfavourable, Non-Squamous Cancer of Unknown Primary (CUP) Progressing after Induction Chemotherapy (CTX) in the Global, Open-Label, Phase II CUPISCO Study

T. Bochtler, A. Krämer,C. Pauli, G. Durán-Pacheco, C. Arslan,F. Bigot,N. Chalabi, N. Cook, A. Italiano,F. Losa, J. Menezes, N. Ma, M. Ozguroglu,R.A. Pazo Cid, J.S. Ross,K-K. Shiu, P. Arni, H. Moch, L. Mileshkin

Annals of Oncology (2024)

引用0浏览0引用

Abstract PR009: Application of Liquid Biopsy-RECIST (LB-RECIST) Criteria to Track Metastatic Colorectal Cancer (mcrc) Molecular Response in First-Line (1L) Setting: Findings from the PLATFORM-B Study

Clinical Cancer Researchno. 21_Supplement (2024)

引用0浏览0引用

Changes in serum CXCL13 levels are associated with outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment

Sara Cabrero-de las Heras,Xavier Hernández-Yagüe,Andrea González,Ferran Losa,Gemma Soler,Cristina Bugés,Iosune Baraibar,Anna Esteve, Miguel Ángel Pardo-Cea,Anne Hansen Ree,Neus Martínez-Bosch, Maria Nieva,Eva Musulén,Sebastian Meltzer, Tania Lobato, Carla Vendrell-Ayats,Cristina Queralt,Pilar Navarro,Clara Montagut, Ferran Grau-Leal, David Camacho,Raquel Legido,Núria Mulet-Margalef,Eva Martínez-Balibrea

medrxiv（2024）

引用0浏览0引用

110P Circulating Tumor DNA (ctdna) to Detect Acquired Resistance to First-Line (1L) Treatment of RASWT Metastatic Colorectal Cancer (mcrc): Insights from the PLATFORM-B Study

V. Martelli,J. Vidal Barrull, C. Fernandez Rodriguez,P. García Alfonso, D. Paez, J. Gibert, V. Alonso,M.A. Gomez España,C. Santos Vivas,G. Duran Ogalla,M.E. Elez Fernandez,R. Garcia-Carbonero,R. Ferreiro Monteagudo,J.L. Manzano Mozo,F. Losa,B. Bellosillo Paricio, J. Tabernero,R. Salazar Soler,E. Aranda Aguilar,C. Montagut Viladot

Annals of Oncology (2024)

引用0浏览0引用

Changes in Serum CXCL13 Levels Are Associated with Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment

Sara Cabrero-de las Heras,Xavier Hernandez-Yague,Andrea Gonzalez,Ferran Losa,Gemma Soler,Cristina Buges,Iosune Baraibar,Anna Esteve, Miguel Angel Pardo-Cea,Anne Hansen Ree,Neus Martinez-Bosch, Maria Nieva,Eva Musulen,Sebastian Meltzer, Tania Lobato, Carla Vendrell-Ayats,Cristina Queralt,Pilar Navarro,Clara Montagut, Ferran Grau-Leal, David Camacho,Raquel Legido,Nuria Mulet-Margalef,Eva Martinez-Balibrea

BIOMEDICINE & PHARMACOTHERAPY (2024)

引用0浏览0引用

Molecularly Guided Therapy Versus Chemotherapy after Disease Control in Unfavourable Cancer of Unknown Primary (CUPISCO): an Open-Label, Randomised, Phase 2 Study

Alwin Kraemer,Tilmann Bochtler,Chantal Pauli,Kai-Keen Shiu,Natalie Cook,Juliana Janoski de Menezes,Roberto A. Pazo-Cid,Ferran Losa,Debbie G. J. Robbrecht,Jiri Tomasek,Cagatay Arslan,Mustafa Ozguroglu,Michael Stahl,Frederic Bigot,Sun Young Kim,Yoichi Naito,Antoine Italiano, Nassera Chalabi,Gonzalo Duran-Pacheco, Chantal Michaud, Jeremy Scarato,Marlene Thomas, Jeffrey S. Ross,Holger Moch,Linda Mileshkin

The Lancetno. 10452 (2024): 527-539

引用0浏览0WOS引用

84P Next-generation Sequencing (NGS) in Metastatic Colorectal Cancer (mcrc): Clinical Utility in Daily Practice in a Comprehensive Cancer Centre

J. C. Ruffinelli Rodriguez, M. Balsa Pena,F. Torrent, D. Lluis Garulo,M. Martinez Villacampa,G. Soler Gonzalez, R. Gallego Sanchez,M. Orrillo Sarmiento,A. Teule,M. Varela,X. Sanjuan,S. Villatoro, N. Ruiz,D. Azuara,D. Cordero,A. Alay Badosa, R. M. Legido-Diaz,L. Raventos,F. Losa,C. Santos Vivas

ANNALS OF ONCOLOGY（2024）

引用0浏览0引用

Circulating Tumor DNA (ctdna) to Detect Acquired Resistance to First-Line (1L) Treatment of RASWT Metastatic Colorectal Cancer (mcrc): Insights from the PLATFORM-B Study

V. Martelli,J. Vidal Barrull,C. Fernandez Rodriguez,P. Garcia Alfonso,D. Paez, J. Gibert,V. Alonso,M. A. Gomez Espana,C. Santos Vivas,G. Duran Ogalla,M. E. Elez Fernandez,R. Garcia-Carbonero,R. Ferreiro Monteagudo,J. L. Manzano Mozo,F. Losa,B. Bellosillo Paricio, J. Tabernero,R. Salazar Soler,E. Aranda Aguilar,C. Montagut Viladot

ANNALS OF ONCOLOGY (2024): S51-S52

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn